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ABSTRACT: The new hybrid-type squaramide-fused amino
alcohol containing both a Brønsted basic site and hydrogen-
bonding sites in the molecule showed a high catalytic activity
as an organocatalyst in the enantioselective domino Michael
addition/cyclization reaction of oxoindolines with cyclic 1,3-
diketones to afford the chiral spiro-conjugated oxindoles
featuring 2-aminopyrans fusing with carbo-heterocyclic ring
systems with excellent chemical yields (up to 98%) and enantioselectivities (up to 95% ee). The obtained chiral spiro-
conjugated 2-aminopyrans bearing quaternary stereogenic carbon center could be used as synthetic precursors for several
natural products that have a broad spectrum of fascinating biological activities.
■ INTRODUCTION
In the enormously progressing field of synthetic organic
chemistry, the construction of carbon−carbon and a carbon−
heteroatom bond is an important strategy for the construction
of complex organic molecules.1 The domino approach is one of
the major tools to construct biologically important complex
molecules and its precursors from simple substrates in one-pot
fashion, which is ecologically and economically benign.2 The
enantioselective domino Michael addition/cyclization reaction
of oxoindoline with cyclic or acyclic 1,3-diketones affords the
synthetically valuable chiral carbo-heterocyclic spiro-oxindoles
A, that are synthetic intermediates for preparing many
biologically active molecules, such as rychnophylline (tetracy-
clic oxindole alkaloid), formosanine (pentacyclic oxindole
alkaloid), elacomine (hemiterpene oxindole alkaloid), and
pyranopyrazole (synthetic dye-stuff), in the field of synthetic
organic chemistry (Scheme 1).3−6
However, the methodology of preparation of vital spiro-
oxindole A, incorporating a chiral spiro-conjugated amino-
pyran framework at C-3 position of oxindoles, is still limited.
Recently, Yuan and his co-workers7 reported the first
enantioselective domino Michael addition/cyclization reaction
of oxoindolines B with acyclic 1,3-diketones C using cupreine
(CPN) organocatalyst to afford chiral spiro-conjugated
oxindoles with 2-aminopyrans framework E in both excellent
chemical yield (up to 99%) and enantioselectivities (up to 97%
ee) (Scheme 2). However, this CPN catalyst did not work
efficiently for the reaction of cyclic 1,3-diketones D with
oxoindolines to afford the chiral spiro-conjugated oxindoles F
with 2-aminopyrans fusing carbo-heterocyclic ring systems at
C-4 and C-5 positions in terms of enantioselectivity (up to 8%
ee), in spite of the obtained products being useful for the
synthesis of biologically important molecules from the point of
view of drug discovery.8
Most recently, we developed the new hybrid-type squar-
amide-fused amino alcohol (SFAA) organocatalysts and the
catalyst was successfully employed in enantioselective nitro-
aldol and Diels−Alder reactions to afford the corresponding
synthetically important chiral products in satisfactory chemical
yields and enantioselectivities.9 On the basis of these reasons,
we planned to apply our newly developed SFAA organocatalyst
for enantioselective domino Michael addition/cyclization
reaction of oxoindolines with cyclic 1,3-diketones, affording
the chiral spiro-conjugated oxindoles with 2-aminopyrans
fusing with carbo-heterocyclic ring systems.
The SFAA organocatalyst possesses multiple functional sites,
such as diamino groups on squaramide part for hydrogen-
bonding with the substrate, tertiary amino group acting as a
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Brønsted base, and phenyl groups acting as steric influence site
for recognition by substrates (Scheme 3). The enantioselective
domino Michael addition/cyclization reaction of oxoindolines
with cyclic 1,3-diketones using SFAA catalyst might proceed
via transition state X, in which the hydroxy functional group on
catalysts might participate in hydrogen-bonding interaction
with squaramide carbonyl oxygen atom. Additionally, the
enolate of cyclic 1,3-diketones might be fixed through
hydrogen-bonding interactions with the ammonium site at
the side chain of the catalyst part. Furthermore, two cyano
groups of oxoindoline might be fixed through two hydrogen-
bonding interactions with two amino hydrogen atoms of the
squaramide unit of the catalyst. The activated enolate
generated from 1,3-diketones might attack stereoselectively
on electron-deficient olefin on oxoindolines from the less
sterically hindered site of the fixed oxoindoline to afford the
chiral Michael adduct, and subsequent intramolecular cycliza-
tion/tautomerization might afford the corresponding chiral
spiro-conjugated oxindoles with 2-aminopyrans fusing carbo-
heterocyclic ring systems in satisfactory chemical yield and
enantioselectivity.
We report herein that the first domino Michael addition/
cyclization reaction of cyclic 1,3-diketones with oxoindolines
using SFAA catalyst afforded the chiral spiro-conjugated
oxindoles with 2-aminopyrans fusing carbo-heterocyclic ring
systems in excellent chemical yields (up to 98%) and with
excellent enantioselectivities (up to 95% ee), although
cupreine catalyst only afforded the spiro products in poor
enantioselectivities (up to 8% ee) when cyclic 1,3-diketones
were used.
■ RESULTS AND DISCUSSION
The catalysts 3a−e with different sizes of heterocyclic ring
systems on the amino alcohol part were easily prepared
according to our previously reported method using the
condensation of squaramide with amino alcohols.9 At the
outset of the study, the domino Michael addition/cyclization
reaction of oxoindolines 1a,b with dimedone 2a was tried using
SFAA catalysts 3a−e (10 mol %) in toluene or tetrahydrofuran
(THF). The results are summarized in Table 1. First, the
reaction using catalyst 3a (10 mol %) was conducted with
oxoindoline 1a and dimedone 2a in toluene at room
temperature (RT) for 24 h but only a trace amount of desired
spiro-pyran 4a was obtained (entry 1). Next, the reactions
using catalysts 3b and 3c were also carried out, respectively,
and the corresponding 4a was afforded in good chemical yields
(3b: 82%, 3c: 90%) but with poor enantioselectivities (3b: 7%
ee, 3c: 9% ee) (entries 2 and 3). Furthermore, the reaction
using catalyst 3b was also conducted in THF (polar aprotic
solvent) but the reaction only afforded 4a as racemate,
although good chemical yield (90%) was obtained (entry 4).
On the basis of these results, we assumed that the use of
sterically bulkier oxoindolines might be effective to control the
enantioselectivity in this reaction.
The reaction of bulkier N-Bn-oxoindoline 1b with 2a using
catalyst 3b was carried out in toluene. Unfortunately, this
reaction also afforded the racemic 4b, although the chemical
Scheme 1. Biological Significance of Chiral Oxindole
Incorporating Spiro-conjugated Amino Framework
Scheme 2. Cupreine-Catalyzed Enantioselective Domino
Michael Addition/Cyclization
Scheme 3. Concept of Domino Michael Addition/
Cyclization Reaction of Oxoindolines with Cyclic 1,3-
Diketones Using SFAA Organocatalyst
ACS Omega Article
DOI: 10.1021/acsomega.8b01271
ACS Omega 2018, 3, 11718−11726
11719
yield was excellent (95%) (entry 5). Moreover, the same
reaction using 3b was examined in THF. Surprisingly, the
enantioselectivity was greatly increased to 77% ee with good
chemical yield (89%) (entry 6). The reaction using 3a was also
carried out in the same reaction conditions as those of 3b.
Similarly, the catalyst 3a showed good catalytic activity to
afford 4b in excellent chemical yield (92%) and with good
enantioselectivity (79% ee) (entry 7). Furthermore, the use of
catalyst 3c was also examined to afford the chiral 4a in
excellent chemical yield (95%) with good enantioselectivity
(75% ee) (entry 8). Encouraged by the results using THF as a
solvent, the reactions using catalysts 3d and 3e were also
carried out in THF, respectively. However, the reaction
afforded 4b in poor enantioselectivities (entries 9 and 10).
Furthermore, this reaction of 1b with 2a using well-known
quinine G and diamine squaramide H catalysts was examined
(entries 11 and 12), respectively. As a result, catalyst G
afforded 4b in both good chemical yield (86%) and
enantioselectivity (70% ee) (entry 11). On the other hand,
catalyst H provided 4b in excellent chemical yield (91%) but
with poor enantioselectivities (24% ee) (entry 12). By these
results, it was found that catalyst 3a possessing pyrrolidine ring
was the most effective in this reaction of 1b with 2a.
To optimize the reaction conditions using superior catalyst
3a, we next examined the molar ratio of catalyst, the effect of
solvents, and the reaction temperatures (Table 2, entries 1−
15). An increase in the catalyst loading amount from 10 to 20
mol % 3a resulted in a remarkable increase in chemical yield
(96%) and unpredicted decrease in enantioselectivity (7% ee),
although the reason was not clear (entry 1). On the other
hand, the catalytic loading of 5 mol % 3a brought about both
increase of chemical yield (95%) and enantioselectivity (83%)
(entry 2). Furthermore, the reaction was also tried in the
presence of 2 mol % 3a to afford the chiral product 4b in
Table 1. Optimization of the Michael Addition/Cyclization Reaction of Oxoindolines 1a,b with Dimedone 2a Using Catalysts
3a−e, G, and H
entrya catalysts 3a−e, G, and H oxoindolines 1a,b solvent time (h) temp (°C) yield (%)b ee (%)c
1 a H toluene 24 RT trace
2 b H toluene 24 RT 82 9
3 c H toluene 24 RT 90 7
4 b H THF 24 0 90 rac
5 b Bn toluene 24 RT 95 rac
6 b Bn THF 48 0 89 77
7 a Bn THF 48 0 92 79
8 c Bn THF 48 0 95 75
9 d Bn THF 48 0 96 10
10 e Bn THF 48 0 97 rac
11 G Bn THF 48 0 86 70
12 H Bn THF 48 0 91 24
aThe reactions were carried out with 1a,b (0.1 mmol) and 2a (0.1 mmol) using catalysts 3a−e, G and H (10 mol %) in above-mentioned solvents
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excellent chemical yield (92%) with good enantioselectivity
(81% ee) (entry 3). To further improve the enantioselectivity
of 4b, we also examined the catalytic activity of 3a at low
temperatures (−10 to −80 °C). Under these conditions, good
enantioselectivities (73−81% ee) were obtained with fairly
good chemical yields (87−92%) (entries 4−6). Next, we
examined the effects of different ethereal solvents, such as
diethyl ether (Et2O), diisopropyl ether (DIPE), and 1,4-
dioxane in this reaction using 5 mol % 3a. From the results, the
enantioselectivities widely decreased in these solvents,
although the chemical yields were good to excellent (entries
7−9). Moreover, the reactions were carried out in chlorinated
solvents, such as dichloromethane (DCM), chloroform, and
1,2-dichloroethane (DCE). However, the chiral 4b was
obtained in good-to-excellent chemical yield (89−96%) and
only poor-to-moderate enantioselectivities (7−51% ee) (en-
tries 10−12). Similarly, the uses of highly polar solvents, such
as dimethylformamide (DMF), dimethylacetamide (DMA),
and MeOH, also afforded racemic 4b with good chemical
yields (89−92%) (entries 13−15). From these results, it
turned out that the use of 5 mol % 3a in THF at 0 °C for 48 h
was the optimal condition for this reaction. In general,
enantiomeric excess in asymmetric reactions strongly depends
on the solvent effect. It might be reasoned that THF
coordinates in the reaction system include both the catalyst
and substrates for forming a better transition state to afford
satisfactory optical purity for this reaction.
Under the optimal reaction conditions, the reactions using a
wide range of oxoindolines 1c−m with cyclic 1,3-diketones
2a−c were examined in the domino Michael addition/
cyclization reaction in the presence of superior catalyst 3a to
afford the corresponding chiral spiro-conjugated 2-amino-
pyrans 4c−r. The results are summarized in Scheme 4. The
reaction of N-para-methoxybenzyl-oxoindoline 1c with dime-
done 2a afforded the corresponding spiro-pyran 4c in both
good chemical yield (89%) and enantioselectivity (81% ee).
However, the use of electron-deficient N-Boc-oxoindoline 1d
gave 4d in good chemical yield (72%) but with poor
enantioselectivity (5% ee). This failure might be due to the
electronic characteristics of 1d, although the reason is not
clear. The best result (92, 95% ee) was obtained in the reaction
of N-methyl-oxoindoline 1e with 2a. The absolute config-
uration of the obtained chiral spiro-pyran (3S)-4e was
determined by X-ray analysis (see the Supporting Informa-
tion). The reactions of N-ethyl and N-methoxymethyl
oxoindolines 1f,g with 2a afforded the corresponding chiral
products 4f and 4g in good-to-excellent chemical yields (4f:
87%, 4g: 95%) and with moderate-to-good enantioselectivities
(4f: 84% ee, 4g: 75% ee), respectively. Furthermore, the
reactions were also conducted using N-acetyl oxoindoline 1h
or silyl-protected N-tert-butyldimethylsilyl oxoindoline 1i with
2a, to afford the chiral spiro-pyrans 4h,i in moderate-to-good
chemical yields (4h: 90%, 4i: 72%) and moderate-to-poor
enantioselectivities (4h: 80% ee, 4i: 9% ee). The use of bulkier
naphthyl-(2-methylene)-oxoindoline 1j also afforded the chiral
4j in good chemical yield (81%) with enantioselectivity (71%
ee). Additionally, the domino Michael addition/cyclization
reaction using N-methyl-oxoindoline 1e was extended to the
reaction with other cyclic 1,3-diketones, such as 1,3-cyclo-
hexadione 2b and 1,3-cyclopentadione 2c, using catalyst 3a.
The reaction of 1e with 2b afforded the desired product 4k in
both good chemical yield and enantioselectivity (4k: 90%, 76%
ee). On the other hand, the reaction between 1e and 2c
afforded product 4l in good chemical yield but with poor
enantioselectivity (4l: 90%, 12% ee). The use of 5-fluoro-N-
methyl-oxoindoline 1k also afforded the corresponding
product 4m in both good chemical yield and enantioselectivity
(4m: 72%, 71% ee).
Next, the reaction of 5-bromo-N-methyl-oxoindoline 1l with
2a was also carried out and the product 4n was obtained in
excellent chemical yield with racemate, although the reason is
not clear. Similarly, the reaction of 1m with 2a also afforded
the anticipated product 4o obtained as racemate but with good
chemical yield (4o: 81%). We also examined the reaction of N-
methyl-oxoindoline 1e with acyclic 1,3-diketones 2d−f using
catalyst 3a. However, the desired products 4p−r were obtained
as racemates, proceeded with a good chemical yield (72−
81%), respectively. The formation of racemates 4p−r may be
for the unfavored interaction of substrates 2d−f with catalyst
3a, respectively, although the reason is not clear. These results
of the reactions of acyclic 1,3-diketones 4p−r are in contrast to
the previously reported results.8 To demonstrate the practical
utility of catalyst 3a, the domino Michael addition/cyclization
reaction between oxoindoline 1e and 2a was conducted on a
gram scale (1e: 1 g) using optimized reaction conditions (3a: 5
mol %, THF, 0 °C, 48 h) and the corresponding product 4e
was obtained in excellent chemical yield (96%). Unfortunately,
the enantioselectivity of 4e was 35% ee (see the Supporting
Information). This result indicated that a detailed examination
of the reaction conditions should be necessary (on a small
scale) for obtaining satisfactory optical purity of 4e for use on
the gram scale.
On the basis of the observed enantiopurity (95% ee) of
chiral spiro-pyran 4e that was obtained from the reaction of 1e
Table 2. Optimization of Reaction Conditions for the











1 20 THF 0 96 7
2 5 THF 0 95 83
3 2 THF 0 92 81
4 5 THF −10 92 73
5 5 THF −50 90 81
6 5 THF −80 87 77
7 5 Et2O 0 82 67
8 5 DIPE 0 89 43
9d 5 1,4-dioxane RT 98 5
10 5 DCM 0 96 7
11 5 chloroform 0 91 13
12 5 DCE 0 89 51
13 5 DMF 0 90 rac
14 5 DMA 0 89 rac
15 5 MeOH 0 92 rac
aThe reactions were carried out with 1b (0.1 mmol) and 2a (0.1
mmol) using catalyst 3a in above-mentioned solvents (0.1 mL).
bIsolated yields. cThe ee were determined by chiral HPLC using
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and 2a using catalyst 3a, the enantioselective reaction course
was proposed as follows (Scheme 5). The configuration of 3a
might be fixed by the hydrogen-bonding interaction between
the hydroxyl hydrogen atom on diphenyl hydroxyl part at side
chain and the squaramide carbonyl group. The active
methylene proton of dimedone 2a is abstracted by basic
tertiary nitrogen in the pyrrolidine ring of 3a, and the
generated enolate species forms hydrogen bond with
ammonium site of 3a. Furthermore, the oxoindoline 1e is
also fixed to catalyst 3a through two hydrogen-bonding
interactions of cyano groups on 2a with two amino hydrogen
atoms of the squaramide part of the catalyst. Among the two
proposed transition states Ts-I and Ts-II, the Michael addition
might proceed through Ts-II that has less steric interactions
between the substrate and enolate species than those of Ts-I
that has larger steric interactions between 1e and enolate
species. Thus, enolate of dimedone 2a attacks the electron-
deficient olefin site of oxoindoline 1e from the side below (si
face) to afford the chiral Michael adduct X. Furthermore,
subsequent intramolecular cyclization leads to the formation of
intermediate Y. Finally, tautomerization of 2-iminopyran Y
might afford the formation of (3S)-4e as the major enantiomer.
■ CONCLUSIONS
We have demonstrated the first successful enantioselective
domino Michael addition/cyclization reaction of cyclic 1,3-
diketones using our new hybrid-type squaramide-fused amino
alcohol (SFAA) organocatalysts 3a−e containing both the
Brønsted basic site and hydrogen-bonding sites. In the used
SFAA catalysts, the catalyst 3a especially showed excellent
catalytic activity in the reaction of oxoindolines 1a−m with
2a−f to afford the quaternary stereogenic chiral spiro-
Scheme 4. Substrate Scope for the Domino Michael Addition/Cyclization Reaction Using Catalyst 3a
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conjugated oxindoles with 2-aminopyrans fusing carbo-
heterocyclic ring systems 4a−r in excellent chemical yields
(up to 98%) with satisfactory-to-excellent enantioselectivities
(up to 95% ee). The obtained chiral spiro-conjugated
oxindoles 4a−r bearing quaternary stereogenic chiral carbon
center may work as efficient synthetic intermediates for the
synthesis of chiral biologically active compounds and for drug
discovery.
■ EXPERIMENTAL SECTION
General Information. All reagents and solvents used in
this work were bought from commercial channels and used
directly. Oxoindolines 1a−m were prepared according to the
literature procedure.10 All reactions were placed under argon
atmosphere in flame-dried 4 mL sample vials inserted with
magnetic beads. Thin-layer chromatography (TLC) was
performed on Merck silica gel 60 F254 plates, and the analytes
were identified under UV light. Flash column chromatography
was performed using silica gel pore size 60N (40−100 μm).
Melting points were recorded with a micro-melting-point
apparatus. IR spectra were recorded with a JASCO 4100
Fourier transform infrared spectrophotometer. 1H and 13C
NMR spectroscopic data were recorded using JEOL JNM-
ECA500 instrument with tetramethylsilane as the internal
standard. X-ray diffraction data of 4e were collected at 93 K on
a Rigaku R-AXIS RAPID diffractometer using multilayer
mirror monochromated Cu Kα radiation. HPLC data were
collected using TOSOH instrument equipped with (UV-8020,
DP-8020, and SD-8022) detectors using CHIRALCEL OD-H
and CHIRALPAK AD-H columns. Optical rotations were
recorded using a JASCO DIP-360 digital polarimeter. High-
resolution mass spectrometry (HRMS) data were collected by
electron impact (EI) and fast atom bombardment (FAB)
modes using Hitachi RMG-GMG and JEOL JNX-DX303
sector instruments.
General Procedure for the Synthesis of Compounds
(4a−r). To a 4 mL sample vial containing 1,3-diketones 2a−f
(0.1 mmol) and catalyst 3a (5 mol %) was added anhydrous
THF (1.0 mL). The reaction mixture was allowed to stir at 0
°C for 1 h, followed by addition of 3-dicyano-2-oxoindolines
1a−j (0.1 mmol) at the same temperature. The reaction
mixture was allowed to be stirred at the same temperature for
48 h. After completion of reaction, indicated by TLC, the
residue was purified by using flash column chromatography
(ethyl acetate/hexane, 4:6). The enantiomeric excess was
determined by chiral HPLC using CHIRALPAK AD-H or
CHIRALCEL OD-H columns.
(3S) -2-Amino-1-benzy l -7 ,7-d imethy l -2 ,5 -doxo-
tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile (4b).
White solid. 92 mg, 98% yield. m.p. 250−251 °C. [α]D24 =
−22 (c = 0.18, MeOH). IR (neat): cm−1 = 2962, 2189, 1706,
1632, 1492, 1470. 1H NMR (500 MHz, dimethyl sulfoxide
(DMSO)-d6, ppm): δ 7.55 (d, J = 7.00 Hz, 2H), 7.40−7.30
(m, 5H), 7.18 (t, J = 7.50 Hz, 1H), 7.02 (t, J = 8.00 Hz, 1H),
6.74 (d, J = 8.00 Hz, 1H), 4.96 (q, J = 16.50, 29.50 Hz, 2H),
2.66 (q, J = 17.50, 25.00 Hz, 2H), 2.27 (d, J = 16.50 Hz, 1H),
2.18 (d, J = 16.50 Hz, 1H), 1.10 (s, 3H), 1.07 (s, 3H) ppm.
13C NMR (125 MHz, DMSO-d6, ppm): 195.2, 176.8, 164.6,
159.0, 142.6, 136.2, 133.6, 128.48, 128.40, 127.2, 127.1, 123.0,
122.7, 117.5, 110.7, 109.0, 57.2, 50.0, 46.6, 43.4, 32.0, 27.7,
27.12. MS (EI): m/z = 425 [M]+, HRMS (EI): calcd for
C26H23N3O3 m/z 425.1748; found: 425.1745. The enantio-
meric excess was determined by chiral HPLC; CHIRALPAK
AD-H column (solvent system 80:20, hexane/isopropyl
alcohol (IPA); flow rate, 1.0 mL/min; temp, 25 °C; detection
UV, 254 nm; retention time, 32.02 min (major) and 41.46 min
(minor), ee = 83%).
(3S)-2-Amino-1-(4-methoxybenzyl)-7,7-dimethyl-2,5-
doxo-tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile
(4c). Brown solid. 70 mg, 89% yield. m.p. 147−149 °C. [α]D24
= −21 (c = 0.18, MeOH). IR (neat) cm−1: 2972, 2189, 1707,
1470, 1370. 1H NMR (500 MHz, DMSO-d6, ppm): δ 7.41 (d,
J = 8.50 Hz, 2H), 7.33 (s, 2H), 7.18−7.06 (m, 2H), 6.94 (t, J =
10.00 Hz, 1H), 6.86 (d, J = 5.00 Hz, 2H), 6.69 (d, J = 8.00 Hz,
1H), 4.83 (q, J = 20.00, 23.50 Hz, 2H), 3.71 (s, 3H), 2.60 (q, J
= 17.50, 29.00 Hz, 2H), 2.15 (dd, J = 16.00, 28.00 Hz, 2H),
1.04 (s, 3H), 1.00 (s, 3H). 13C NMR (125 MHz, DMSO-d6,
ppm): 195.0, 176.6, 164.5, 158.9, 158.4, 142.6, 133.6, 128.9,
128.5, 128.2, 122.9, 122.5, 117.4, 113.7, 110.6, 109.0, 57.2,
55.0, 49.9, 46.5, 42.7, 32.0, 27.6, 27.0. MS (EI): m/z = 455
[M]+, HRMS (EI): calcd for C27H25N3O3 m/z 455.1834;
found: 455.1838. The enantiomeric excess was determined by
chiral HPLC; CHIRALPAK AD-H column (solvent system
80:20, hexane/IPA; flow rate, 1.0 mL/min; temp, 25 °C;
detection UV, 254 nm; retention time, 48.74 min (major) and
92.45 min (minor), ee = 81%).
Scheme 5. Plausible Reaction Course for Domino Michael








Pale yellow solid. 57 mg, 72% yield. m.p. 135−136 °C. [α]D24
= −10 (c = 0.18, MeOH). IR (neat): cm−1 = 3309, 3179, 2189,
1720, 1715, 1610, 1407, 1309. 1H NMR (500 MHz, DMSO-
d6, ppm): δ 7.87 (d, J = 8.00 Hz, 1H), 7.30 (t, J = 10.00 Hz,
1H), 7.12 (t, J = 7.50 Hz, 1H), 7.02 (d, J = 6.50 Hz, 1H), 4.99
(s, 2H), 2.56−2.46 (m, 2H), 2.23−2.13 (m, 2H), 1.65 (s,
12H), 1.11 (s, 3H), 1.06 (s, 3H). 13C NMR (125 MHz,
DMSO-d6, ppm): 195.0, 175.5, 163.9, 158.3, 149.1, 139.8,
131.4, 129.4, 125.0, 123.2, 116.3, 115.5, 112.2, 84.6, 50.4, 40.9,
32.4, 28.6, 28.3, 27.9. MS (FAB): m/z = 436 [M]+, HRMS
(FAB): calcd for C24H26N3O5 m/z 436.1845; found: 436.1863.
The enantiomeric excess was determined by chiral HPLC;
CHIRALPAK AD-H column (solvent system 80:20, hexane/
IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection UV, 254
nm; retention time, 47.78 min (major) and 53.24 min (minor),
ee = 5%).
(3S) -2-Amino-1-methyl -7 ,7-d imethyl -2 ,5-doxo-
tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile (4e).
White solid. 86 mg, 92% yield. m.p. 195−196 °C. [α]D24 =
−23 (c = 0.18, MeOH). IR (neat): cm−1 = 3308, 3176, 2189,
1720, 1715, 1612, 1432, 1402. 1H NMR (500 MHz, DMSO-
d6, ppm): δ 7.29 (s, 1H), 7.25 (t, J = 8.00 Hz, 1H), 7.04 (d, J =
7.50 Hz, 1H), 7.00−6.96 (m, 2H), 3.12 (s, 3H), 2.56 (d, J =
4.00 Hz, 2H), 2.11 (q, J = 16.00, 32.50 Hz, 2H), 1.02 (s, 3H),
0.98 (s, 3H). 13C NMR (125 MHz, DMSO-d6, ppm): 194.9,
176.6, 164.3, 158.9, 143.5, 137.4, 133.5, 128.9, 128.2, 125.3,
122.8, 122.4, 117.2, 110.7, 108.2, 57.0, 49.9, 32.0, 27.5, 27.0,
26.4, 21.1. MS (EI): m/z = 349 [M]+, HRMS (FAB): calcd for
C20H19N3O3 m/z 349.3814; found: 349.3820. The enantio-
meric excess was determined by chiral HPLC; CHIRALCEL
OD-H column (solvent system 80:20, hexane/IPA; flow rate,
0.5 mL/min; temp, 25 °C; detection UV, 254 nm; retention
time, 95.54 min (major) and 48.69 min (minor), ee = 95%).
(3S) -2 -Amino-1- (ethy l ) -7 ,7-d imethyl -2 ,5-doxo-
tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile (4f).
White solid. 56 mg, 87% yield. m.p. 280 °C. [α]D
12 = −33
(c = 0.18, DCM). IR (neat): cm−1 = 3312, 3305, 2193, 1674,
1458. 1H NMR (500 MHz, CDCl3, ppm): δ 7.31−7.24 (m,
1H), 7.08−6.96 (m, 2H), 6.89 (d, J = 8.0 Hz, 1H), 4.81 (s,
2H), 3.92−3.76 (m, 2H), 2.63−2.41 (m, 2H), 2.29−2.0 (m,
2H), 1.39−1.30 (m, 3H), 1.12 (s, 3H), 1.06 (s, 3H). 13C NMR
(125 MHz, CDCl3, ppm): δ 195.0, 176.2, 163.8, 158.4, 142.7,
133.0, 129.2, 123.2, 122.9, 116.3, 111.9, 108.8, 62.1, 50.6, 41.0,
35.4, 32.4, 28.7, 27.7, 12.2. MS (EI): m/z = 363 [M]+, HRMS
(EI): calcd for C21H21N3O3 m/z 363.1511; found: 363.1585.
The enantiomeric excess was determined by chiral HPLC;
CHIRALPAK AD-H column (solvent system 80:20, hexane/
IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection UV, 254




(4g). White solid. 49 mg, 95% yield. m.p. 109 °C. [α]D
12 =
−105 (c = 0.12, DCM). IR (neat): cm−1 = 3402, 3317, 2938,
2182, 1711, 1684. 1H NMR (500 MHz, CDCl3, ppm): δ 7.32−
7.25 (m, 1H), 7.14−7.00 (m, 3H), 5.26−5.16 (m, 2H), 4.92
(s, 2H), 3.46 (s, 3H), 2.62−2.42 (m, 2H), 2.28−2.09 (m, 2H),
1.12 (s, 3H), 1.07 (s, 3H). 13C NMR (125 MHz, CDCl3,
ppm): δ 195.17, 177.32, 164.00, 158.41, 142.00, 132.25,
129.41, 123.66, 123.18, 116.52, 111.86, 110.07, 72.29, 61.71,
60.59, 56.63, 50.55, 47.34, 41.01, 32.41, 28.68, 27.74, 21.24,
14.34. MS (EI): m/z = 379 [M]+, HRMS (EI): calcd for
C21H21N3O4 m/z 379.1512; found: 379.1537. The enantio-
meric excess was determined by chiral HPLC; CHIRALPAK
AD-H column (solvent system 80:20, hexane/IPA; flow rate,
1.0 mL/min; temp, 25 °C; detection UV, 254 nm; retention
time, 20.7 min (major) and 31.48 min (minor), ee = 75%).
(3S)-2-Amino-1-(acetyl) -7 ,7-dimethyl-2 ,5-doxo-
tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile (4h).
White solid. 59 mg, 90% yield. m.p. 242 °C. [α]D
14 = −99 (c =
0.15, DCM). IR (neat): cm−1 = 3379, 3305, 2939, 2200, 1712,
1619, 1472. 1H NMR (500 MHz, CDCl3, ppm): δ 8.26 (d, J =
8.6 Hz, 1H), 7.33 (t, J = 7.4 Hz, 1H), 7.17 (t, J = 7.7 Hz, 1H),
7.04 (d, J = 7.4 Hz, 1H), 4.97 (s, 2H), 2.69 (s, 3H), 2.60−2.45
(m, 2H), 2.35−2.11 (m, 3H), 1.13 (s, 3H), 1.07 (s, 3H). 13C
NMR (125 MHz, CDCl3, ppm): δ 195.2, 177.7, 171.0, 164.0,
158.2, 140.0, 131.5, 129.6, 125.7, 123.0, 116.8, 116.1, 112.2,
68.7, 61.7, 53.6, 50.3, 47.6, 40.9, 32.5, 28.5, 27.8, 26.7, 22.3.
MS (EI): m/z = 377 [M]+, HRMS (EI): calcd for C21H19N3O4
m/z 377.1321; found: 377.1373. The enantiomeric excess was
determined by chiral HPLC; CHIRALPAK AD-H column
(solvent system 80:20, hexane/IPA; flow rate, 1.0 mL/min;
temp, 25 °C; detection UV, 254 nm; retention time, 37.09 min
(major) and 28.67 min (minor), ee = 80%).
(3S)-2-Amino-1-(tert-butyldimethylsilyl)-7,7-dimethyl-2,5-
doxo-tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile
(4i). Yellow solid. 32 mg, 72% yield. m.p. 119 °C. [α]D
14 = −18
(c = 0.21, DCM). IR (neat): cm−1 = 3345, 3309, 2829, 2215,
1725, 1470, 1719, 1677. 1H NMR (500 MHz, CDCl3, ppm): δ
7.26 (tt, J = 8.7, 3.4 Hz, 1H), 7.06−7.00 (m, 1H), 7.00−6.91
(m, 2H), 4.69 (d, J = 10.3 Hz, 2H), 2.58−2.40 (m, 2H), 2.29−
2.09 (m, 2H), 1.12 (s, 3H), 1.07 (s, 12H), 0.56 (s, 3H), 0.52
(s, 3H). 13C NMR (125 MHz, CDCl3, ppm): δ 194.1, 183.7,
163.5, 157.8, 146.1, 134.9, 128.7, 123.2, 122.5, 116.3, 113.1,
112.4, 50.5, 40.9, 32.3, 28.8, 27.5, 26.4, 19.9, −3.2, −3.6. MS
(EI): m/z = 449 [M]+, HRMS (EI): calcd for C25H31N3O3Si
m/z 449.2145; found: 449.2137. The enantiomeric excess was
determined by chiral HPLC; CHIRALPAK AD-H column
(solvent system 80:20, hexane/IPA; flow rate, 1.0 mL/min;
temp, 25 °C; detection UV, 254 nm; retention time, 4.2 min
(major) and 5.99 min (minor), ee = 9%).
(3S)-2-Amino-1-(methylenenaphthyl)-7,7-dimethyl-2,5-
doxo-tetrahydrospiro(chromene-4,3-indoline)-3-carbonitrile
(4j).White solid. 42 mg, 81% yield. m.p. 188−190 °C. [α]D24 =
−11 (c = 0.18, solvent). IR (neat): cm−1 = 3395, 3196, 2996,
2189, 1782, 1676, 1610. 1H NMR (500 MHz, DMSO-d6,
ppm): δ 8.03 (s, 1H), 7.90−7.87 (m, 2H), 7.79−7.77 (m, 1H),
7.61 (d, J = 8.50 Hz, 1H), 7.51−7.42 (m, 2H), 7.38 (s, 2H),
7.36 (s, 1H), 7.10 (t, J = 7.50 Hz, 2H), 6.96 (t, J = 7.50 Hz,
1H), 6.74 (d, J = 8.00 Hz, 1H), 5.08 (dd, J = 16.50, 68.00 Hz,
2H), 2.62 (q, J = 17.50, 28.00 Hz, 2H), 2.19 (dd, J = 16.00,
41.00 Hz, 2H), 1.06 (s, 3H), 1.02 (s, 3H). 13C NMR (125
MHz, DMSO-d6, ppm): 195.1, 176.8, 164.6, 159.0, 142.6,
133.7, 133.6, 132.9, 132.2, 128.3, 128.0, 127.6, 127.5, 126.2,
125.8, 125.5, 125.2, 123.0, 122.6, 110.7, 108.9, 57.1, 50.0, 46.7,
43.4, 32.0, 27.6, 27.0. MS (EI): m/z = 475 [M]+, HRMS
(FAB): calcd for C30H25N3O3 m/z 475.1823; found: 475.1894.
The enantiomeric excess was determined by chiral HPLC;
CHIRALCEL OD-H column (solvent system 80:20, hexane/
IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection UV, 254
nm; retention time, 45.82 min (major) and 66.26 min (minor),
ee = 71%).
(3S)-2-Amino-1-methyl-2,5-doxo-tetrahydrospiro-
(chromene-4,3-indoline)-3-carbonitrile (4k). White solid. 68
ACS Omega Article
DOI: 10.1021/acsomega.8b01271
ACS Omega 2018, 3, 11718−11726
11724
mg, 90% yield. m.p. 267−268 °C. [α]D24 = −130 (c = 0.1,
DCM). IR (neat): cm−1 = 3302, 2187, 1723, 1671, 1629, 1293.
1H NMR (500 MHz, DMSO-d6, ppm): δ 7.30−7.22 (m, 3H),
7.08−7.05 (m, 1H), 7.00−6.95 (m, 2H), 3.12 (s, 3H), 2.70−
2.61 (m, 2H), 2.25−2.14 (m, 2H), 1.936−1.88 (m, 2H). 13C
NMR (125 MHz, DMSO-d6, ppm): δ 195.2, 176.7, 166.3,
158.8, 143.5, 133.7, 128.4, 123.0, 122.5, 117.3, 111.8, 108.2,
57.0, 46.6, 36.4, 26.8, 26.4, 19.8. MS (EI): m/z = 321 [M]+,
HRMS (EI): calcd for C18H15N3O3 m/z 321.3312; found:
321.1145. The enantiomeric excess was determined by chiral
HPLC; CHIRALPAK AD-H column (solvent system 80:20,
hexane/IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection
UV, 254 nm; retention time, 12.81 min (major) and 28.44 min
(minor), ee = 76%).
(S)-2-Amino-1′-methyl-2′,5-dioxo-6,7-dihydro-5H-spiro-
[cyclopenta-pyran-4,3′-indoline]-3-carbonitrile (4l). White
solid. 31 mg, 90% yield. m.p. 288 °C. [α]D
14 = −33 (c =
0.16, DCM). IR (neat): cm−1 = 3345, 3216, 2945, 2200, 1723,
1678, 1478. 1H NMR (500 MHz, DMSO-d6, ppm): δ 7.12 (s,
2H), 6.92−6.78 (m, 1H), 6.78−6.64 (m, 1H), 6.64−6.47 (m,
2H), 2.70 (s, 3H), 2.44−2.29 (m, 2H), 1.96−1.82 (m, 2H).
13C NMR (125 MHz, DMSO-d6, ppm): δ 199.9, 177.8, 175.2,
160.8, 143.5, 131.3, 129.1, 124.0, 122.9, 117.5, 114.8, 108.6,
67.1, 56.0, 46.3, 33.2, 26.5, 25.2, 25.0. MS (EI): m/z = 307
[M]+, HRMS (EI): calcd for C17H13N3O3 m/z 307.0917;
found: 307.0966. The enantiomeric excess was determined by
chiral HPLC; CHIRALPAK AD-H column (solvent system
80:20, hexane/IPA; flow rate, 1.0 mL/min; temp, 25 °C;
detection UV, 254 nm; retention time, 13.15 min (major) and
21.42 min (minor), ee = 12%).
(3S)-2-Amino-5′-fluoro-1′,7,7-trimethyl-2′,5-dioxo-
5,6,7,8-tetrahydrospiro[chromene-4,3′-indoline]-3-carboni-
trile (4m). White solid. 64 mg, 71% yield. m.p. 211 °C. [α]D
24
= −34 (c = 0.23, DCM). IR (neat): cm−1 = 3308, 3176, 2189,
1720, 1715, 1612, 1432, 1402. 1H NMR (500 MHz, CD3OD,
ppm): δ 7.04 (td, J = 8.9, 2.9 Hz, 1H), 6.98 (q, J = 4.2 Hz,
1H), 6.92 (dd, J = 7.7, 2.6 Hz, 1H), 3.25 (s, 3H), 2.68−2.55
(m, 2H), 2.29−2.22 (m, 2H), 1.07 (s, 6H). 13C NMR (125
MHz, CD3OD, ppm): δ 197.7, 179.5, 167.0, 162.2, 161.1,
160.2, 140.9, 117.9, 116.0, 115.8, 112.1, 111.9, 110.5, 51.3,
41.5, 33.2, 28.4, 27.0. MS (EI): m/z = 367 [M]+, HRMS
(FAB): calcd for C20H18FN3O3 m/z 367.1312; found:
367.1336. The enantiomeric excess was determined by chiral
HPLC; CHIRALPAK AD-H column (solvent system 80:20,
hexane/IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection
UV, 254 nm; retention time, 32.51 min (major) and 29.39 min
(minor), ee = 71%).
2-Amino-5′-bromo-1′,7,7-trimethyl-2′,5-dioxo-5,6,7,8-
tetrahydrospiro[chromene-4,3′-indoline]-3-carbonitrile (4n).
Brown solid. 57 mg, 92% yield. m.p. 242 °C. [α]D
24 = −10 (c =
0.30, MeOH). IR (neat): cm−1 = 3310, 3146, 2199, 1721,
1715, 1612, 1432, 1402. 1H NMR (500 MHz, CD3OD) δ
7.34−7.27 (m, 1H), 7.14−7.08 (m, 1H), 6.99 (d, J = 7.7 Hz,
1H), 3.23 (s, 3H), 2.62 (q, J = 17.6 Hz, 2H), 2.27−2.13 (m,
2H), 1.11 (s, 3H), 1.09 (s, 3H). 13C NMR (125 MHz,
CD3OD, ppm): δ 197.7, 179.3, 167.1, 161.2, 143.7, 136.7,
129.8, 129.6, 124.5, 117.9, 111.8, 110.8, 51.3, 41.5, 33.2, 28.1,
27.0. MS (EI): m/z = 428 [M]+, HRMS (FAB): calcd for
C20H18BrN3O3 m/z 428.0523; found: 428.0592. The enantio-
meric excess was determined by chiral HPLC; CHIRALPAK
AD-H column (solvent system 80:20, hexane/IPA; flow rate,
1.0 mL/min; temp, 25 °C; detection UV, 254 nm; retention
time, 31.27 min (minor) and 82.45 min (major), racemate).
Ethyl 2-Amino-1′,7,7-trimethyl-2′,5-dioxo-5,6,7,8-
tetrahydrospiro[chromene-4,3′-indoline]-3-carboxylate
(4o).White solid. 65 mg, 81% yield. m.p. 233 °C. [α]D
24 = −10
(c = 0. 12, MeOH). IR (neat): cm−1 = 3415, 3322, 3293, 2198,
1725, 1674, 1483. 1H NMR (500 MHz, DMSO-d6, ppm): δ
7.86 (s, 2H), 7.29 (s, 2H), 7.08 (s, 1H), 6.83−6.61 (m, 2H),
3.03 (s, 3H), 2.53−2.44 (m, 4H), 2.07−1.85 (m, 2H), 0.93 (s,
3H), 0.86 (s, 3H), 0.65 (s, 3H). 13C NMR (125 MHz, DMSO-
d6, ppm): δ 194.9, 178.3, 167.6, 162.7, 159.3, 145.3, 135.0,
128.4, 127.6, 122.1, 121.4, 113.0, 107.0, 75.9, 58.9, 50.6, 46.1,
31.7, 27.8, 26.7, 26.2, 13.6. MS (EI): m/z = 396 [M]+, HRMS
(EI): calcd for C22H24N2O5 m/z 396.1611; found: 396.1683.
The enantiomeric excess was determined by chiral HPLC;
CHIRALPAK AD-H column (solvent system 80:20, hexane/
IPA; flow rate, 1.0 mL/min; temp, 25 °C; detection UV, 254
nm; retention time, 41.65 min (major) and 14.95 min (minor),
racemate).
3′-Acetyl-6′-amino-2′-ethoxy-1-methyl-2-oxospiro-
[indoline-3,4′-pyran]-5′-carbonitrile (4p).White solid. 31 mg,
72% yield. m.p. 228 °C. [α]D
24 = −22 (c = 0.11, MeOH). IR
(neat): cm−1 = 3420, 3324, 3290, 2198, 1724, 1645, 1479. 1H
NMR (500 MHz, CDCl3, ppm): δ 7.29 (td, J = 7.7, 1.2 Hz,
1H), 7.15−7.09 (m, 1H), 7.09−7.02 (m, 1H), 6.84 (t, J = 6.9
Hz, 1H), 4.80 (s, 2H), 3.94−3.68 (m, 2H), 3.25 (s, 3H), 2.40
(s, 3H), 0.86 (t, J = 7.50 Hz, 3H). 13C NMR (125 MHz,
CDCl3, ppm): δ 177.4, 164.7, 159.7, 158.5, 143.5, 133.3, 129.3,
123.6, 123.3, 116.6, 108.3, 105.1, 60.8, 26.7, 19.2, 13.5. MS
(EI): m/z = 339 [M]+, HRMS (EI): calcd for C18H17N3O4 m/
z 339.1256; found: 339.1224. The enantiomeric excess was
determined by chiral HPLC; CHIRALPAK AD-H column
(solvent system 80:20, hexane/IPA; flow rate, 1.0 mL/min;
temp, 25 °C; detection UV, 254 nm; retention time, 10.1 min
(minor) and 11.72 min (major), racemate).
3′-Acetyl-6′-amino-1,2′-dimethyl-2-oxospiro[indoline-
3,4′-pyran]-5′-carbonitrile (4q). White solid. 48 mg, 81%
yield. m.p. 180 °C. [α]D
24 = −21 (c = 0.13, MeOH). IR (neat):
cm−1 = 3379, 3305, 2939, 2200, 1712, 1619, 1471. 1H NMR
(500 MHz, DMSO-d6, ppm): δ 7.26 (td, J = 7.7, 1.1 Hz, 1H),
7.18 (s, 2H), 7.08 (dd, J = 7.4, 1.1 Hz, 1H), 7.02−6.95 (m,
2H), 3.12 (s, 3H), 2.31 (s, 3H), 2.08 (s, 3H). 13C NMR (125
MHz, DMSO-d6, ppm): δ 197.3, 177.1, 159.3, 157.0, 143.5,
133.5, 128.7, 123.0, 122.6, 117.5, 114.9, 108.4, 56.4, 49.0, 31.4,
26.4, 19.6. MS (EI): m/z = 309 [M]+, HRMS (EI): calcd for
C17H15N3O3 m/z 309.1112; found: 309.1112. The enantio-
meric excess was determined by chiral HPLC; CHIRALPAK
AD-H column (solvent system 80:20, hexane/IPA; flow rate,
1.0 mL/min; temp, 25 °C; detection UV, 254 nm; retention
time, 13.66 min (major) and 16.72 min (minor), racemate).
2′-Amino-5′-benzoyl-1,6′-dimethyl-2-oxospiro[indoline-
3,4′-pyran]-3′-carbonitrile (4r). White solid. 48 mg, 79%
yield. m.p. 180 °C. [α]D
24 = −11 (c = 0.22, MeOH). IR (neat):
cm−1 = 3371, 3315, 2929, 2200, 1712, 1619, 1481. 1H NMR
(500 MHz, CD3OD, ppm): δ 7.78−7.62 (m, 2H), 7.56 (t, J =
7.4 Hz, 1H), 7.49−7.28 (m, 3H), 7.24 (t, J = 7.7 Hz, 1H), 6.99
(t, J = 7.4 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 3.23 (s, 3H), 1.77
(s, 3H). 13C NMR (125 MHz, CD3OD, ppm): δ 195.9, 162.5,
156.7, 139.9, 134.6, 130.6, 130.2, 130.0, 125.5, 124.6, 109.9,
27.1, 20.0. MS (EI): m/z = 371 [M]+, HRMS (EI): calcd for
C22H17N3O3 m/z 371.2780; found: 371.2783. The enantio-
meric excess was determined by chiral HPLC; CHIRALPAK
AD-H column (solvent system 80:20, hexane/IPA; flow rate,
1.0 mL/min; temp, 25 °C; detection UV, 254 nm; retention
time, 25.46 min (minor) and 28.12 min (major), racemate).
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